Menu Back to Global-Labeling-Conference


Conference: March 14-15, 2024

DIA’s Global Labeling Conference is designed for professionals in medical product labeling and related disciplines as they work to develop and manage clear and accurate labeling information for the safe and effective use of prescription drugs, biologics, and medical devices. The efforts of these professionals are key to providing essential information needed by providers, patients, and payers to make decisions about product access, prescription, and use. Influences such as digital technology, patient centricity, evolving product classes, and changing regulations require the use of informed, systematic approaches throughout the labeling cycle to ensure the development and availability of current, compliant information in all regions where products are marketed.

This conference provides a forum for exchange among regulators and industry peers to update their knowledge of key local and global labeling policies and to examine the impact of changes on regulatory compliance. Most importantly, through interactive discussions with expert panels and peer-to-peer exchange, participants will share approaches, processes, and tools to ensure the availability of effective labeling content meeting the needs of patients, consumers, and prescribers.

While we develop our 2024 agenda, please take a moment to review the 2022 final agenda.


Want to learn more about Global Labeling Conference? You've come to the right site!
DIA Global Annual Meeting


Learn more

Who should attend?

  • Meeting Designed For

    • Labeling
    • Regulatory Affairs/Drug Review and Approval Process
    • Clinical Safety/Pharmacovigilance
    • Pharmacoepidemiology
    • Medical Affairs and Communications
    • Medical Writing
    • Clinical Research and Development
    • Product Research and Development Alliances
    • Quality Control/Quality Assurance
    • Marketing/Advertising/Promotion

Program Committee

  • Kathy  Salazar, MA, MBA
    Kathy Salazar, MA, MBA Head, Global Labeling Implementation, Global Labeling COE
    Janssen Research & Development/Johnson & Johnson, United States
  • Rie  Matsui, RPh
    Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC
    Pfizer Inc, Japan
  • Deborah  Bebbington
    Deborah Bebbington Head Global Labeling
    Bayer Plc, United Kingdom
  • Lauren  Brunke, PharmD, RPh
    Lauren Brunke, PharmD, RPh Senior Director – GRA-NA Global Labeling Department (GoLD)
    Eli Lilly and Co, United States
  • Theresa  Brunone, MA, MS
    Theresa Brunone, MA, MS Head-Labelling Compliance and Implementation, Global Labeling
    GlaxoSmithKline, United States
  • Megann  Looker
    Megann Looker Executive Director, Head of Global Labeling
    Jazz Pharmaceuticals, United Kingdom
  • Gerrit  Nijveldt, MSc
    Gerrit Nijveldt, MSc Global Labeling Consultant
    Opus Regulatory Inc., United States
  • Hayley  Parker, PhD, MSc
    Hayley Parker, PhD, MSc Vice President Regulatory Affairs
    PepGen, United States
  • Mary Beth  Wilusz
    Mary Beth Wilusz Head, Regulatory Labeling Operations and Compliance
    Daiichi Sankyo, Inc., United States
  • Representative Invited
    Representative Invited DIA, United States
  • Steven  Bass, PhD
    Steven Bass, PhD President
    Bass Biopharm Consulting Group LLC, United States
  • Su-Yueh  Lin
    Su-Yueh Lin Sr. Labeling Consultant, Regulatory Affairs
Load More

Contact us

Registration Questions?

Send Email

Additional Information

Discover DIA’s Live In-Person Events

Digital Learning Catalog

DIA Learning: eLearning Soultions